Homepage PFG MedComm

$ 13.00

4.6 (102) In stock

MM+M announces 2024's 40 Under 40 honorees

Christopher Ross on LinkedIn: If you want to know experts in medical communications and strategy after…

PFG MedComm

Blog

Thoughts on Havas Health Plus for account?

Clinical and Patient Reported Outcomes of Pre- and Postsurgical Treatment of Symptomatic Uterine Leiomyomas: A 12-Month Follow-up Review of TRUST, a Surgical Randomized Clinical Trial Comparing Laparoscopic Radiofrequency Ablation and Myomectomy

PFG MedComm - Overview, News & Similar companies

Home MM+M 40 Under 40 2024

Homepage PFG MedComm

PFG MedComm

Clinical and Patient Reported Outcomes of Pre- and Postsurgical Treatment of Symptomatic Uterine Leiomyomas: A 12-Month Follow-up Review of TRUST, a Surgical Randomized Clinical Trial Comparing Laparoscopic Radiofrequency Ablation and Myomectomy